Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
N-[Tosyl-D-Prolinyl]Amino-Ethanethiol is a synthetic small molecule belonging to the class of N,N-disubstituted p-toluenesulfonamides. It has been studied as an experimental compound, primarily for its activity as an inhibitor of thymidylate synthase, an essential enzyme in pyrimidine metabolism. Thymidylate synthase inhibition is a validated anticancer strategy due to its role in DNA synthesis and repair. The compound was notably used in structure-based drug design studies employing "tethering" strategies to identify and optimize weak-binding fragments into more potent inhibitors. It has not been approved for clinical use and remains at the experimental stage[1][2][3][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on N-[Tosyl-D-Prolinyl]Amino-Ethanethiol.